Patents by Inventor Nathalie Kertesz

Nathalie Kertesz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Polypeptide compounds for inhibiting angiogenesis and tumor growth
    Patent number: 9533026
    Abstract: In certain embodiments, this present invention provides polypeptide compositions, including compositions containing a modified polypeptide, and methods for inhibiting Ephrin B2 or EphB4 activity. In other embodiments, the present invention provides methods and compositions for treating cancer or for treating angiogenesis-associated diseases.
    Type: Grant
    Filed: May 6, 2013
    Date of Patent: January 3, 2017
    Assignee: VASGENE THERAPEUTICS, INC
    Inventors: Valery Krasnoperov, Nathalie Kertesz, Ramachandra Reddy, Parkash Gill, Sergey Zozulya
  • Monoclonal antibodies and diagnostic uses thereof
    Patent number: 9410957
    Abstract: The disclosure relates to antibodies to the preferentially expressed antigen in melanoma (PRAME), and the synovial sarcoma X breakpoint 2 (SSX-2) antigens, methods of use, and diagnostic kits thereof. In exemplary embodiments, the disclosure relates to monoclonal antibodies to specific epitopes of the PRAME and SSX-2 antigens and methods of using such antibodies.
    Type: Grant
    Filed: August 5, 2014
    Date of Patent: August 9, 2016
    Assignee: MANNKIND CORPORATION
    Inventors: Nathalie Kertesz, Sutao Zhu, Chih-Sheng Chiang
  • Polypeptide compounds for inhibiting angiogenesis and tumor growth
    Patent number: 8981062
    Abstract: In certain embodiments, this present invention provides polypeptide compositions (e.g., antibodies and antigen binding portions thereof that bind to EphB4), and methods for inhibiting EphB4 activity. In other embodiments, the present invention provides methods and compositions for treating cancer or for treating angiogenesis-associated diseases.
    Type: Grant
    Filed: June 6, 2011
    Date of Patent: March 17, 2015
    Assignee: Vasgene Theapeutics, Inc
    Inventors: Valery Krasnoperov, Nathalie Kertesz, Ramachandra Reddy, Parkash Gill, Sergey Zozulya
  • MONOCLONAL ANTIBODIES AND DIAGNOSTIC USES THEREOF
    Publication number: 20150044704
    Abstract: The disclosure relates to antibodies to the preferentially expressed antigen in melanoma (PRAME), and the synovial sarcoma X breakpoint 2 (SSX-2) antigens, methods of use, and diagnostic kits thereof. In exemplary embodiments, the disclosure relates to monoclonal antibodies to specific epitopes of the PRAME and SSX-2 antigens and methods of using such antibodies.
    Type: Application
    Filed: August 5, 2014
    Publication date: February 12, 2015
    Inventors: Nathalie KERTESZ, Sutao ZHU, Chih-Sheng CHIANG
  • Monoclonal antibodies and diagnostic uses thereof
    Patent number: 8846872
    Abstract: The disclosure relates to antibodies to the preferentially expressed antigen in melanoma (PRAME), and the synovial sarcoma X breakpoint 2 (SSX-2) antigens, methods of use, and diagnostic kits thereof. In exemplary embodiments, the disclosure relates to monoclonal antibodies to specific epitopes of the PRAME and SSX-2 antigens and methods of using such antibodies.
    Type: Grant
    Filed: November 18, 2010
    Date of Patent: September 30, 2014
    Assignee: MannKind Corporation
    Inventors: Nathalie Kertesz, Sutao Zhu, Chih-Sheng Chiang
  • POLYPEPTIDE COMPOUNDS FOR INHIBITING ANGIOGENESIS AND TUMOR GROWTH
    Publication number: 20140107030
    Abstract: In certain embodiments, this present invention provides polypeptide compositions, including compositions containing a modified polypeptide, and methods for inhibiting Ephrin B2 or EphB4 activity. In other embodiments, the present invention provides methods and compositions for treating cancer or for treating angiogenesis-associated diseases.
    Type: Application
    Filed: May 6, 2013
    Publication date: April 17, 2014
    Applicant: VasGene Therapeutics, Inc.
    Inventors: Valery Krasnoperov, Nathalie Kertesz, Ramachandra Reddy, Parkash Gill, Sergey Zozulya
  • POLYPEPTIDE COMPOUNDS FOR INHIBITING ANGIOGENESIS AND TUMOR GROWTH
    Publication number: 20130344075
    Abstract: In certain embodiments, this present invention provides polypeptide compositions (e.g., antibodies and antigen binding portions thereof that bind to EphB4), and methods for inhibiting EphB4 activity. In other embodiments, the present invention provides methods and compositions for treating cancer or for treating angiogenesis-associated diseases.
    Type: Application
    Filed: June 6, 2011
    Publication date: December 26, 2013
    Applicant: VASGENE THERAPEUTICS, INC.
    Inventors: Valery Krasnoperov, Nathalie Kertesz, Ramachandra Reddy, Parkash Gill, Sergey Zozulya
  • MONOCLONAL ANTIBODIES AND DIAGNOSTIC USES THEREOF
    Publication number: 20130029359
    Abstract: The disclosure relates to antibodies to the preferentially expressed antigen in melanoma (PRAME), and the synovial sarcoma X breakpoint 2 (SSX-2) antigens, methods of use, and diagnostic kits thereof. In exemplary embodiments, the disclosure relates to monoclonal antibodies to specific epitopes of the PRAME and SSX-2 antigens and methods of using such antibodies.
    Type: Application
    Filed: November 18, 2010
    Publication date: January 31, 2013
    Applicant: MANNKIND CORPORATION
    Inventors: Nathalie Kertesz, Sutao Zhu, Chih-Sheng Chiang
  • POLYPEPTIDE COMPOUNDS FOR INHIBITING ANGIOGENESIS AND TUMOR GROWTH
    Publication number: 20120277162
    Abstract: In certain embodiments, this present invention provides polypeptide compositions, including compositions containing a modified polypeptide, and methods for inhibiting Ephrin B2 or EphB4 activity. In other embodiments, the present invention provides methods and compositions for treating cancer or for treating angiogenesis-associated diseases.
    Type: Application
    Filed: March 15, 2012
    Publication date: November 1, 2012
    Applicant: VASGENE THERAPEUTICS, INC.
    Inventors: Valery Krasnoperov, Nathalie Kertesz, Ramachandra Reddy, Parkash Gill, Sergey Zozulya
  • Polypeptide compounds for inhibiting angiogenesis and tumor growth
    Patent number: 8273858
    Abstract: In certain embodiments, this present invention provides polypeptide compositions, and methods for inhibiting Ephrin B2 or EphB4 activity. In other embodiments, the present invention provides methods and compositions for treating cancer or for treating angiogenesis-associated diseases.
    Type: Grant
    Filed: June 2, 2008
    Date of Patent: September 25, 2012
    Assignee: VasGene Therapeutics, Inc.
    Inventors: Valery Krasnoperov, Nathalie Kertesz, Ramachandra Reddy, Parkash Gill, Sergey Zozulya
  • Polypeptide compounds for inhibiting angiogenesis and tumor growth
    Patent number: 8063183
    Abstract: In certain embodiments, this present invention provides polypeptide compositions, and methods for inhibiting Ephrin B2 or EphB4 activity. In other embodiments, the present invention provides methods and compositions for treating cancer or for treating angiogenesis-associated diseases.
    Type: Grant
    Filed: October 6, 2006
    Date of Patent: November 22, 2011
    Assignee: VasGene Therapeutics, Inc.
    Inventors: Valery Krasnoperov, Nathalie Kertesz, Ramachandra Reddy, Parkash Gill, Sergey Zozulya
  • Polypeptide compounds for inhibiting angiogenesis and tumor growth
    Patent number: 7977463
    Abstract: In certain embodiments, this present invention provides polypeptide compositions (e.g., antibodies and antigen binding portions thereof that bind to EphB4), and methods for inhibiting EphB4 activity. In other embodiments, the present invention provides methods and compositions for treating cancer or for treating angiogenesis-associated diseases.
    Type: Grant
    Filed: March 11, 2005
    Date of Patent: July 12, 2011
    Assignee: VasGene Therapeutics, Inc.
    Inventors: Valery Krasnoperov, Nathalie Kertesz, Ramachandra Reddy, Parkash Gill, Sergey Zozulya
  • POLYPEPTIDE COMPOUNDS FOR INHIBITING ANGIOGENESIS AND TUMOR GROWTH
    Publication number: 20110129482
    Abstract: In certain embodiments, this present invention provides polypeptide compositions, and methods for inhibiting Ephrin B2 or EphB4 activity. In other embodiments, the present invention provides methods and compositions for treating cancer or for treating angiogenesis-associated diseases.
    Type: Application
    Filed: November 23, 2010
    Publication date: June 2, 2011
    Applicant: VASGENE THERAPEUTICS, INC.
    Inventors: Valery Krasnoperov, Sergey Zozulya, Nathalie Kertesz, Ramachandra Reddy, Parkash Gill
  • Polypeptide compounds for inhibiting angiogenesis and tumor growth
    Patent number: 7862816
    Abstract: In certain embodiments, this present invention provides polypeptide compositions, and methods for inhibiting Ephrin B2 or EphB4 activity. In other embodiments, the present invention provides methods and compositions for treating cancer or for treating angiogenesis-associated diseases.
    Type: Grant
    Filed: March 12, 2004
    Date of Patent: January 4, 2011
    Assignee: Vasgene Therapeutics, Inc.
    Inventors: Valery Krasnoperov, Nathalie Kertesz, Ramachandra Reddy, Parkash Gill, Sergey Zozulya
  • Polypeptide compounds for inhibiting angiogenesis and tumor growth
    Publication number: 20100261653
    Abstract: In certain embodiments, this present invention provides polypeptide compositions, including compositions containing a modified polypeptide, and methods for inhibiting Ephrin B2 or EphB4 activity. In other embodiments, the present invention provides methods and compositions for treating cancer or for treating angiogenesis-associated diseases.
    Type: Application
    Filed: September 14, 2009
    Publication date: October 14, 2010
    Applicant: VasGene Therapeutics, Inc.
    Inventors: Valery Krasnoperov, Nathalie Kertesz, Ramachandra Reddy, Parkash Gill, Sergey Zozulya
  • Polypeptide compounds for inhibiting angiogenesis and tumor growth
    Publication number: 20090155251
    Abstract: In certain embodiments, this present invention provides polypeptide compositions, and methods for inhibiting Ephrin B2 or EphB4 activity. In other embodiments, the present invention provides methods and compositions for treating cancer or for treating angiogenesis-associated diseases.
    Type: Application
    Filed: June 2, 2008
    Publication date: June 18, 2009
    Applicant: VasGene Therapeutics, Inc.
    Inventors: Valery Krasnoperov, Sergey Zozulya, Nathalie Kertesz, Ramachandra Reddy, Parkash Gill
  • Polypeptide Compounds for Inhibiting Angiogenesis and Tumor Growth
    Publication number: 20080131436
    Abstract: In certain embodiments, this present invention provides polypeptide compositions (e.g., antibodies and antigen binding portions thereof that bind to EphB4), and methods for inhibiting EphB4 activity. In other embodiments, the present invention provides methods and compositions for treating cancer or for treating angiogenesis-associated diseases.
    Type: Application
    Filed: March 11, 2005
    Publication date: June 5, 2008
    Applicant: VasGene Therapeutics, Inc.
    Inventors: Valery Krasnoperov, Nathalie Kertesz, Ramachandra Reddy, Parkash Gill, Sergey Zozulya
  • Polypeptide compounds for inhibiting angiogenesis and tumor growth
    Patent number: 7381410
    Abstract: In certain embodiments, this present invention provides polypeptide compositions, and methods for inhibiting Ephrin B2 or EphB4 activity. In other embodiments, the present invention provides methods and compositions for treating cancer or for treating angiogenesis-associated diseases.
    Type: Grant
    Filed: September 23, 2004
    Date of Patent: June 3, 2008
    Assignee: Vasgene Therapeutics, Inc.
    Inventors: Valery Krasnoperov, Sergey Zozulya, Nathalie Kertesz, Ramachandra Reddy, Parkash Gill
  • Polypeptide compounds for inhibiting angiogenesis and tumor growth
    Publication number: 20070031435
    Abstract: In certain embodiments, this present invention provides polypeptide compositions, and methods for inhibiting Ephrin B2 or EphB4 activity. In other embodiments, the present invention provides methods and compositions for treating cancer or for treating angiogenesis-associated diseases.
    Type: Application
    Filed: October 6, 2006
    Publication date: February 8, 2007
    Applicant: VasGene Therapeutics, Inc.
    Inventors: Valery Krasnoperov, Sergey Zozulya, Nathalie Kertesz, Ramachandra Reddy, Parkash Gill
  • Polypeptide compounds for inhibiting angiogenesis and tumor growth
    Publication number: 20060204512
    Abstract: In certain embodiments, this present invention provides polypeptide compositions, including compositions containing a modified polypeptide, and methods for inhibiting Ephrin B2 or EphB4 activity. In other embodiments, the present invention provides methods and compositions for treating cancer or for treating angiogenesis-associated diseases.
    Type: Application
    Filed: September 23, 2005
    Publication date: September 14, 2006
    Applicant: VasGene Therapeutics, Inc.
    Inventors: Valery Krasnoperov, Nathalie Kertesz, Ramachandra Reddy, Parkash Gill, Sergey Zozulya